Rep. Russ Fulcher

Radiation Exposure Compensation Act Amendments of 2021 This bill expands two programs that compensate individuals who were exposed to radiation during certain nuclear testing or uranium mining and subsequently developed medical conditions, including cancers. First, the bill expands and extends a program that compensates individuals who were exposed to radiation from atmospheric nuclear testing or other sources and subsequently developed specified cancers. Under current law, this program compensates individuals who were present in a designated geographic area during a period of nuclear testing and certain individuals employed in uranium mining. The bill expands the designated areas to include Colorado, Idaho, Montana, New Mexico, and Guam and additional areas in Arizona, Nevada, and Utah; makes more individuals who worked in uranium mining eligible for the program; increases the amount of compensation awarded to and provides medical benefits for eligible claimants; and extends for 19 years following the bill's enactment the fund that supports this program and the statute of limitations for filing claims (currently, the program terminates on July 10, 2022). Second, the bill makes certain individuals employed in uranium mines or mills eligible for a program that compensates workers, including Department of Energy employees and contractors, for illnesses caused by occupational exposure to radiation and hazardous substances during development and testing of the nation's nuclear weapons stockpile. The bill also establishes a grant program in the National Institute of Environmental Health Sciences for institutions of higher education to study the epidemiological impacts of uranium mining and milling among individuals without occupational exposure.

Northern Spotted Owl Habitat Improvement Act of 2021 The bill provides statutory authority for the rule published on January 15, 2021, by the U.S. Fish and Wildlife Service entitled Endangered and Threatened Wildlife and Plants; Revised Designation of Critical Habitat for the Northern Spotted Owl .

Fairness for Federal Contractors Act of 2021 This bill prohibits executive agencies from requiring contractors to receive a COVID-19 vaccination. The bill also requires the Government Accountability Office to study the degree to which Executive Order 14042 (Ensuring Adequate COVID Safety Protocols for Federal Contractors) caused disruptions to federal contracts, supply chains, and transportation systems.

This joint resolution nullifies a Department of Labor emergency temporary standard for preventing the transmission of COVID-19 in employment settings. Under the standard issued on November 5, 2021, employers with 100 or more employees must require their onsite employees to either be fully vaccinated against COVID-19 or undergo weekly COVID-19 testing.

Uyghur Stop Oppressive Sterilizations Act or the Uyghur SOS Act This bill expands existing visa-blocking sanctions to cover certain high-ranking foreign government officials who are responsible for coercive population control policies, such as forced abortions, with a focus on those responsible for such policies against ethnic minority groups in China. Specifically, the Department of State may not issue a visa to a foreign national who is a head of state, head of government, or cabinet-level minister and responsible for establishing or enforcing such policies if the policies are (1) imposed with the intent to destroy a national, ethnic, racial, or religious group; or (2) targeting ethnic minority groups (e.g., Uyghurs, Kazakhs, or Tibetans) or individuals peacefully expressing internationally-recognized human rights in China. (Currently, these sanctions do not apply to any foreign government officials at these higher ranks.) The State Department must make a public announcement each time sanctions are imposed under this bill. The bill also requires the State Department to provide all appropriate assistance to women who belong to an ethnic minority group in China and who have experienced sexual violence, torture, or coercive population control policies.

This bill provides statutory authority for the rule published on August 27, 2019, by the Department of the Interior entitled Endangered and Threatened Wildlife and Plants; Regulations for Listing Species and Designating Critical Habitat . The rule addressed procedures and criteria used for (1) listing or removing species from the lists of endangered and threatened wildlife and plants, and (2) designating critical habitat.

Supplying America Needs Truckers Aged 18 Act or the SANTA 18 Act This bill exempts drivers who transport goods from a port of entry and another place within the same state from age restrictions and other requirements that apply to federal commercial driver's licenses.

No Vaccine Mandate Act This bill prohibits certain funding made available for the Departments of Labor, Health and Human Services, and Education and related agencies from being used for implementing or enforcing a rule that requires a COVID-19 vaccine.

Maddy summaryHRES 754 is a non-binding resolution expressing the House of Representatives' opposition to proposed "punitive natural gas taxes" on U.S. businesses, families, and workers. It cites claims that such taxes would raise average energy bills by 17%, reduce GDP by $9 billion, and eliminate 90,000 jobs, while disproportionately harming low-income households. The resolution argues that opposing these taxes supports U.S. energy security, national security, and continued leadership in reducing emissions through domestic natural gas production. As a procedural resolution, it does not create law but formally states the House's position against this policy approach.

Lower Costs, More Cures Act of 2021 This bill establishes and modifies several programs and requirements to address prescription drug prices. The bill modifies provisions under Medicare and Medicaid relating to prescription drug coverage and price transparency. Among other changes, the bill requires the Centers for Medicare & Medicaid Services to publish certain information, as reported by pharmacy benefit managers (PBMs), relating to generic dispensing rates, drug discounts and rebates, and payments between PBMs, health plans, and pharmacies; caps annual out-of-pocket spending under the Medicare prescription drug benefit; allows prescription drug plan sponsors under the Medicare prescription drug benefit to offer additional plans in a region; requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with PBMs under Medicaid; and allows states to include in the Medicaid Drug Rebate Program covered outpatient drugs that are provided as part of physician or outpatient hospital services. The bill also generally modifies other provisions relating to the regulation and costs of generic and brand-name drugs. Among other changes, the bill prohibits the manufacturer of a brand-name, generic, or biosimilar drug from entering into certain agreements to resolve or settle a patent infringement claim in connection with the sale of a drug or biological product; permanently allows high deductible health plans to waive deductibles for insulin and associated products; and establishes the position of Chief Pharmaceutical Negotiator in the Office of the U.S. Trade Representative.